“…We have investigated the interaction of colloidal bismuth subcitrate (CBS) with alcohol dehydrogenase and our results demonstrate that bismuth can effectively inhibit the enzyme. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Nonalcoholic steatohepatitis (NASH) is the progressive subtype of non-alcoholic fatty liver disease and potentiates risks for both hepatic and metabolic diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Liver is the primary organ for fructose metabolism, recent studies suggest that excessive fructose intake is a driving force in non-alcoholic fatty liver disease (NAFLD). Dietary fructose metabolism begins at the intestine, along with its metabolites, may influence gut barrier and microbiota community, and contribute to increased nutrient absorption and lipogenic substrates overflow to the liver. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Nonalcoholic steatohepatitis (NASH) is a progressed stage of non-alcoholic fatty liver disease, and available therapeutic strategies for NASH are limited. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This paper describes an electrospun polyvinyl alcohol (PVA) fibrous membranes loaded with antibacterial drugs. …”
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Fetal alcohol exposure affects 1 in 100 children making it the leading cause of mental retardation in the US. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Blue light-initiated alcoholic reversible addition-fragmentation chain transfer (RAFT) dispersion polymerization of benzyl methacrylate (BzMA) using bis (acyl) phosphane oxide (BAPO) as the photo-initiator is developed to prepare diblock copolymer nano-objects. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of chronic liver disease characterized by aberrant accumulation of triglycerides (TG) in hepatocytes without excessive alcohol consumption. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease world-wide, and currently therapeutic options for NAFLD are limited. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Berberine is a natural plant alkaloid isolated from a diverse range of genera, it obtains anti-inflammatory, anti-obesity, and hepatoprotective properties, and is a promising agent for non-alcoholic steatohepatitis (NASH). Farnesoid X receptor (FXR) is a bile acid receptor and a drug target for NASH, however, the underlying mechanisms of berberine on regulating FXR are still unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Non-alcoholic fatty liver disease (NAFLD) is a clinically progressive illness that can advance from simple fatty liver to non-alcoholic hepatitis and liver fibrosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The present study investigated the impact of saponins of tomato extract (STE) on non-alcoholic fatty liver disease (NAFLD). The findings demonstrated that introducing STE in NAFLD mice revealed promising results in ameliorating symptoms of oxidative stress, lipid metabolism disorders, visceral fat deposition and fatty liver disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Fire and smoke suppressions of polyvinyl alcohol (PVA) aerogels are urgently required due to the serious fire hazard they present. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) keeps growing recently. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the current study, one case of coronary artery bypass grafting combined with liver transplantation was assessed, with the patient exhibiting advanced alcoholic liver cirrhosis. A coronary artery bypass graft was performed to relieve angina pectoris. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Huazhi-Rougan (HZRG) formula is a Traditional Chinese medicine prescription, and has been widely used to treat non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Alcohol abuse can lead to alcoholic hepatitis (AH), a worldwide public health issue with high morbidity and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso